Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-17-015752

Director sold 8,580 shares at $40.00 ($343,200)

  • Director acquired 8,580 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
GELBMAN RONALD G Director 2017-03-24 Option exercise +8,580 $27.24 $233,719 58,268 D
GELBMAN RONALD G Director 2017-03-24 Sale −8,580 $40.00 $343,200 49,688 D
Derivatives
GELBMAN RONALD G Director 2017-03-24 Option exercise · Non-qualified Stock Option (Right to Buy) −8,580 0 D
Open-market sales · 8,580 sh · avg $40.00 · $343,200
Loading xslF345X03/form4.xml…